8468 (ATX) News
Track canonical SquawkNews coverage tagged to ATX, 8468. This hub brings together deduplicated headlines about yhd, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 2 indexed stories across 2 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
ATX reports final Phase VI assays at B2B breccia
ATX reports final Phase VI assays extending B2B breccia about 200m south in Hole ATXD19A; ATXD19B ended in 37m at 1.72% CuEq.
EQUITY | Aug 26, 2026, 09:06 PM UTC
L
Amplia Announces Changes to Board’s Leadership Roles
Melbourne, Australia, July 06, 2026 (GLOBE NEWSWIRE) -- Amplia Therapeutics Limited (ASX
EQUITY | Jul 06, 2026, 12:45 PM UTC